6 hours CVS’s stock rises nearly 2% on report of meeting with hedge fund Glenview Capital MarketWatch
The reported meeting signals potential changes to improve shareholder value after weak stock performance.
The reported meeting signals potential changes to improve shareholder value after weak stock performance.